MIAMI & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced ...
BUDAPEST, HUNGARY-- Genetic Immunity ( OTCBB : PWRV ) is pleased to announce the GMP approval of its manufacturing facility. The development of the GMP manufacturing process and the facility was ...
BUBENDORF, Switzerland, March 24, 2025 (GLOBE NEWSWIRE) -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing ...
Exothera, a CDMO specializing in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for ...
The Good Manufacturing Practice (GMP) is a system (and part of quality assurance programme) to ensure that the pharmaceutical products are consistently produced and controlled according to quality ...
This ANVISA GMP certification inspection is the first of its kind for a purpose-built cannabis facility in North America and rare for a global GMP facility that manufactures botanical CBD and THC. The ...
The European Union Good Manufacturing Practice (EU GMP) certification has helped Indian drug manufacturing plants, processes, documentation, and quality systems to align and comply with rigorous ...
The European Bank for Reconstruction and Development (EBRD) is promoting further growth in domestic production of ...
Flora's cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback